Caris Life Sciences, Inc. Common Stock (CAI) — Net Asset Quality Index
Caris Life Sciences, Inc. Common Stock (CAI) has a Net Asset Quality Index of 51.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.16 Billion minus total liabilities of $568.90 Million yields net assets of $593.49 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check CAI asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Caris Life Sciences, Inc. Common Stock Net Asset Quality Index Over Time (2003–2025)
This chart shows how Caris Life Sciences, Inc. Common Stock's Net Asset Quality Index has evolved across 22 annual periods from 2003 to 2025. As of March 2026, the index stands at 51.1%, representing net assets of $593.49 Million against total assets of $1.16 Billion USD. See CAI working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Caris Life Sciences, Inc. Common Stock (2003–2025)
The table below presents the year-by-year Net Asset Quality Index for Caris Life Sciences, Inc. Common Stock from 2003 to 2025, covering 22 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see CAI company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 51.3% | $577.31 Million | $1.13 Billion | $548.36 Million | ▲ +778.3 pp |
| 2024 | -727.0% | $-2.50 Billion | $343.73 Million | $2.84 Billion | ▼ -207.5 pp |
| 2023 | -519.5% | $-2.14 Billion | $412.90 Million | $2.56 Billion | ▼ -282.2 pp |
| 2022 | -237.3% | $-1.70 Billion | $717.42 Million | $2.42 Billion | ▼ -264.1 pp |
| 2020 | 26.9% | $702.24 Million | $2.61 Billion | $1.91 Billion | ▲ +3.0 pp |
| 2019 | 23.9% | $693.24 Million | $2.90 Billion | $2.21 Billion | ▲ +0.6 pp |
| 2018 | 23.3% | $701.13 Million | $3.01 Billion | $2.31 Billion | ▲ +0.1 pp |
| 2017 | 23.2% | $563.85 Million | $2.43 Billion | $1.87 Billion | ▲ +0.9 pp |
| 2016 | 22.3% | $457.50 Million | $2.06 Billion | $1.60 Billion | ▼ -1.0 pp |
| 2015 | 23.2% | $461.26 Million | $1.99 Billion | $1.53 Billion | ▼ -1.4 pp |
| 2014 | 24.7% | $442.90 Million | $1.80 Billion | $1.35 Billion | ▼ -0.1 pp |
| 2013 | 24.8% | $415.13 Million | $1.68 Billion | $1.26 Billion | ▼ -0.2 pp |
| 2012 | 25.0% | $346.85 Million | $1.39 Billion | $1.04 Billion | ▼ -1.1 pp |
| 2011 | 26.1% | $248.74 Million | $953.37 Million | $704.63 Million | ▼ -6.1 pp |
| 2010 | 32.2% | $197.67 Million | $613.45 Million | $415.78 Million | ▼ -2.3 pp |
| 2009 | 34.5% | $129.10 Million | $374.08 Million | $244.99 Million | ▲ +6.9 pp |
| 2008 | 27.6% | $113.79 Million | $412.63 Million | $298.84 Million | ▼ -8.9 pp |
| 2007 | 36.5% | $131.15 Million | $359.10 Million | $227.95 Million | ▲ +26.7 pp |
| 2006 | 9.8% | $27.75 Million | $283.00 Million | $255.25 Million | ▼ -8.5 pp |
| 2005 | 18.3% | $32.99 Million | $180.66 Million | $147.67 Million | ▲ +5.2 pp |
| 2004 | 13.1% | $23.82 Million | $181.96 Million | $158.14 Million | ▲ +5.2 pp |
| 2003 | 7.9% | $15.18 Million | $193.10 Million | $177.92 Million | — |